Semler Scientific (NASDAQ:SMLR) Price Target Lowered to $80.00 at Maxim Group

Key Points

• Maxim Group has lowered its price target for Semler Scientific from $95.00 to $80.00, maintaining a "buy" rating, indicating a potential upside of 172.76% from current prices.
• Multiple brokerages have adjusted their ratings, with Cantor Fitzgerald lowering its target to $60.00 and Wall Street Zen downgrading the stock from "buy" to "sell."
• Semler Scientific reported a quarterly earnings per share (EPS) of $5.04, significantly surpassing analysts' estimates, with revenue also exceeding expectations.

Semler Scientific (NASDAQ:SMLR - Get Free Report) had its price objective decreased by investment analysts at Maxim Group from $95.00 to $80.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Maxim Group's target price points to a potential upside of 172.76% from the stock's current price.

Several other brokerages have also issued reports on SMLR. Cantor Fitzgerald decreased their price target on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 6th. Wall Street Zen downgraded shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Benchmark initiated coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They set a "buy" rating and a $101.00 target price on the stock. Four analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Semler Scientific has a consensus rating of "Buy" and a consensus price target of $78.00.

Semler Scientific Price Performance

Shares of NASDAQ:SMLR traded down $0.16 during trading on Friday, reaching $29.33. 231,594 shares of the company traded hands, compared to its average volume of 668,638. The firm has a market capitalization of $434.23 million, a PE ratio of 12.08 and a beta of 1.39. Semler Scientific has a 52 week low of $21.77 and a 52 week high of $81.56. The company has a quick ratio of 0.58, a current ratio of 0.60 and a debt-to-equity ratio of 0.25. The company's 50 day moving average is $34.07 and its two-hundred day moving average is $35.54.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported $5.04 EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The business had revenue of $8.22 million during the quarter, compared to the consensus estimate of $8.10 million.

Institutional Investors Weigh In On Semler Scientific

Large investors have recently made changes to their positions in the business. BNP Paribas Financial Markets bought a new position in shares of Semler Scientific during the 4th quarter worth $30,000. Cetera Investment Advisers purchased a new position in shares of Semler Scientific in the fourth quarter worth about $965,000. D. E. Shaw & Co. Inc. bought a new stake in shares of Semler Scientific in the fourth quarter valued at approximately $439,000. Nuveen Asset Management LLC lifted its stake in shares of Semler Scientific by 396.9% during the 4th quarter. Nuveen Asset Management LLC now owns 124,548 shares of the company's stock valued at $6,726,000 after buying an additional 99,482 shares in the last quarter. Finally, Pinnacle Wealth Management LLC bought a new position in Semler Scientific in the 4th quarter worth approximately $2,279,000. 49.37% of the stock is owned by hedge funds and other institutional investors.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.